Lucid Diagnostics Inc.
LUCD
$1.20
-$0.01-0.83%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 4.35M | 4.19M | 3.80M | 2.98M | 2.43M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.35M | 4.19M | 3.80M | 2.98M | 2.43M |
| Cost of Revenue | 7.06M | 6.38M | 6.33M | 6.27M | 5.95M |
| Gross Profit | -2.71M | -2.19M | -2.53M | -3.28M | -3.52M |
| SG&A Expenses | 36.41M | 35.24M | 33.99M | 32.77M | 35.54M |
| Depreciation & Amortization | 587.00K | 994.00K | 1.39M | 1.79M | 1.98M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 50.30M | 49.32M | 48.37M | 47.94M | 50.91M |
| Operating Income | -45.95M | -45.13M | -44.57M | -44.96M | -48.48M |
| Income Before Tax | -45.53M | -44.82M | -46.65M | -47.03M | -52.67M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -45.53 | -44.82 | -46.65 | -47.03 | -52.67 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -45.53M | -44.82M | -46.65M | -47.03M | -52.67M |
| EBIT | -45.95M | -45.13M | -44.57M | -44.96M | -48.48M |
| EBITDA | -44.79M | -43.56M | -42.58M | -42.57M | -45.98M |
| EPS Basic | -1.07 | -1.13 | -1.23 | -1.27 | -1.26 |
| Normalized Basic EPS | -0.52 | -0.60 | -0.62 | -0.65 | -0.74 |
| EPS Diluted | -1.07 | -1.13 | -1.23 | -1.27 | -1.26 |
| Normalized Diluted EPS | -0.52 | -0.60 | -0.62 | -0.65 | -0.74 |
| Average Basic Shares Outstanding | 201.98M | 185.93M | 177.42M | 171.04M | 167.00M |
| Average Diluted Shares Outstanding | 201.98M | 185.93M | 177.42M | 171.04M | 167.00M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |